• Curis regained compliance with Nasdaq’s $1 minimum bid price rule on July 24, 2026, ending a listing deficiency.
• Nasdaq placed the stock under a one-year discretionary panel monitor through July 24, 2027, raising delisting risk if any new deficiency emerges.
• During the monitor period, Nasdaq staff can issue an immediate delist determination without allowing a compliance plan or extra cure time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001108205-26-000105), on July 30, 2026, and is solely responsible for the information contained therein.